The Massachusetts Appeals Court has partially reinstated a wrongful death lawsuit against Philip Morris USA Inc., vacating a previous defense judgment that had dismissed allegations of consumer protection law violations. This decision revives claims that the tobacco company engaged in deceptive practices under the state’s consumer protection statutes.
The case centers on the estate of Frederick Douglas Greene Jr., who passed away from smoking-related illnesses. His representatives argue that Philip Morris misled consumers about the health risks associated with their products, particularly Marlboro Lights cigarettes. The plaintiffs contend that the company marketed these cigarettes as a safer alternative to regular Marlboros, despite evidence suggesting otherwise.
In its ruling, the Appeals Court found that the lower court had erred in dismissing the consumer protection claims. The appellate judges emphasized that there was sufficient evidence to suggest that Philip Morris’s marketing practices could have misled consumers, warranting further examination in court.
This decision aligns with previous legal actions against Philip Morris. For instance, in the case of Philip Morris USA Inc. v. Williams, the U.S. Supreme Court addressed punitive damages awarded to the widow of a smoker who died from lung cancer, highlighting the ongoing legal challenges faced by tobacco companies regarding their marketing practices.
The reinstatement of the consumer protection claims means that the case will return to the lower court for further proceedings. This development underscores the judiciary’s ongoing scrutiny of tobacco companies’ marketing strategies and their compliance with consumer protection laws.
Philip Morris has yet to issue a public statement regarding the Appeals Court’s decision. Legal experts anticipate that this case could set a precedent for similar lawsuits, potentially influencing how tobacco products are marketed and sold in Massachusetts and beyond.
As the case progresses, it will be closely watched by both legal professionals and public health advocates, given its potential implications for consumer rights and corporate accountability in the tobacco industry.